Post by Erik Thiele Orberg

Attending Physician and Research Group Leader | Board Certified Oncologist, Clinical Microbiome Expert

🚀 New Publication Alert! 📝 We’re excited to share that our latest review has just been published in Med by Cell Press! 🎉 In this work titled “Microbiota-derived metabolites: Key modulators of cancer immunotherapies”, we dive deep into how various microbial metabolites in the gut modulate immune response and affect the outcome of cancer treatments like ICIs, CAR-T or allo-SCT, offering perspectives on future microbiome-based therapies and how immunotherapy could be tailored to individual patients. 🔗 https://lnkd.in/dYKpBTwJ A big thank you to everyone who contributed to this project: Markus Perl, Matthias A. Fante, Konstantin Herfeld, Julian N. Scherer, Hendrik Poeck University Hospital Regensburg Bavarian Cancer Research Center, Regensburg Universitätsklinikum Würzburg LIT - Leibniz Institute for Immunotherapy We’d love to hear your thoughts — feel free to read, share, and reach out! #Publication #TeamWork #NewReview #Microbiome #CancerResearch

Post content